FR2103403A1 - - Google Patents

Info

Publication number
FR2103403A1
FR2103403A1 FR7130252A FR7130252A FR2103403A1 FR 2103403 A1 FR2103403 A1 FR 2103403A1 FR 7130252 A FR7130252 A FR 7130252A FR 7130252 A FR7130252 A FR 7130252A FR 2103403 A1 FR2103403 A1 FR 2103403A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7130252A
Other versions
FR2103403B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Publication of FR2103403A1 publication Critical patent/FR2103403A1/fr
Application granted granted Critical
Publication of FR2103403B1 publication Critical patent/FR2103403B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7130252A 1970-08-20 1971-08-19 Expired FR2103403B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7012303 1970-08-20

Publications (2)

Publication Number Publication Date
FR2103403A1 true FR2103403A1 (fr) 1972-04-14
FR2103403B1 FR2103403B1 (fr) 1975-08-01

Family

ID=19810821

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7130252A Expired FR2103403B1 (fr) 1970-08-20 1971-08-19

Country Status (8)

Country Link
AU (1) AU3217771A (fr)
BE (1) BE771598A (fr)
DE (1) DE2141640A1 (fr)
FR (1) FR2103403B1 (fr)
GB (1) GB1358098A (fr)
HU (1) HU162460B (fr)
IE (1) IE35507B1 (fr)
ZA (1) ZA715217B (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2185414A1 (fr) * 1972-05-25 1974-01-04 Schering Ag
FR2193611A1 (fr) * 1972-07-24 1974-02-22 Hoffmann La Roche
EP0200391A3 (en) * 1985-04-22 1987-06-03 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid derivatives
EP0234708A1 (fr) * 1986-01-23 1987-09-02 Merck Frosst Canada Inc. Acides tétrahydrocarbazole 1-alcanoiques

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146542A (en) * 1978-06-12 1979-03-27 Hoffmann-La Roche Inc. Dihydrocarbazole acetic acid and esters thereof
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2185414A1 (fr) * 1972-05-25 1974-01-04 Schering Ag
FR2193611A1 (fr) * 1972-07-24 1974-02-22 Hoffmann La Roche
EP0200391A3 (en) * 1985-04-22 1987-06-03 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1h-carbazole-1-acetic acid derivatives
EP0234708A1 (fr) * 1986-01-23 1987-09-02 Merck Frosst Canada Inc. Acides tétrahydrocarbazole 1-alcanoiques

Also Published As

Publication number Publication date
GB1358098A (en) 1974-06-26
IE35507B1 (en) 1976-03-03
ZA715217B (en) 1972-04-26
IE35507L (en) 1972-02-20
HU162460B (fr) 1973-02-28
AU3217771A (en) 1973-02-15
DE2141640A1 (de) 1972-02-24
BE771598A (nl) 1972-02-21
FR2103403B1 (fr) 1975-08-01

Similar Documents

Publication Publication Date Title
AR204384A1 (fr)
ATA96471A (fr)
AU1146470A (fr)
AU2044470A (fr)
AU1473870A (fr)
AU1336970A (fr)
AU1326870A (fr)
AU2085370A (fr)
AU2017870A (fr)
AU1833270A (fr)
AU1716970A (fr)
AU1517670A (fr)
AU1603270A (fr)
AU1872870A (fr)
AU2144270A (fr)
AU1277070A (fr)
AU1343870A (fr)
AU1247570A (fr)
AU2131570A (fr)
AU2130770A (fr)
AU2130570A (fr)
AU2119370A (fr)
AU1581370A (fr)
AU1591370A (fr)
AU1189670A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse